Versant Venture Capital VI, L.P., 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 95,983 shares at $33.26 ($3.1M) on 2020-10-06, disclosed to the SEC on 2020-10-08.
Scheduled sale ($3.1M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.26 | 2,110 | $70K | 2.3% |
| 2 | $33.26 | 2,110 | $70K | 2.3% |
| 3 | $33.26 | 15,980 | $531K | 17.3% |
| 4 | $33.26 | 15,980 | $531K | 17.3% |
| 5 | $0.00 | 4,131 | $0 | 0.0% |
| 6 | $33.56 | 3,246 |
| $109K |
| 3.5% |
| 7 | $33.56 | 3,246 | $109K | 3.5% |
| 8 | $33.56 | 24,590 | $825K | 26.9% |
| 9 | $33.56 | 24,590 | $825K | 26.9% |
| Total | $32.00 avg | 95,983 | $3.1M | 100% |
| Filing → |
| GLUE | SELL | 2024-10-30 | $2.8M | — | Filing → |
| GLUE | SELL | 2024-09-24 | $14.8M | — | Filing → |
| TPST | SELL | 2024-08-12 | $1.4M | — | Filing → |